C
Resistin
Novel & Emerging BiomarkersLab test / biomarkerriskpartially modifiable
12
evidence score
PREVENT status
Not a PREVENT input variable.
Causal support
trial evidence
Score components
lit volume: 6meta-analyses: 0trials: 6genetic: 0MR bonus:
References (3)
0 meta-analyses / systematic reviews- Circadian misalignment increases cardiovascular disease risk factors in humans. — Proceedings of the National Academy of Sciences of the United States of America 2016 · PMID 26858430
- Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients. — Journal of diabetes research 2015 · PMID 25883983
- Resistin: insulin resistance to malignancy. — Clinica chimica acta; international journal of clinical chemistry 2014 · PMID 25128719
Clinical trials (3)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT03377465 | Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis | COMPLETED | INTERVENTIONAL | ADMA (asymmetric dimethylarginine) , NTproBNP (N-terminal pro b-type natriuretic peptide), IL-6 (Interleukin 6), Adiponectina, Leptine, Syndecan, Resistin |
| NCT01396564 | Comparison of the Effects of Pioglitazone and Metformin on Resistin Plasma Levels in Children With Type 2 Diabetes | COMPLETED | INTERVENTIONAL | Metformin, Pioglitazone |
| NCT04455204 | Implication of Adipokines, Inflammation, Insulin Resistance and Endothelial Dysfunction in the Pathogenesis of Preeclampsia and in Pregnancy Related Complications | COMPLETED | OBSERVATIONAL | Serum asymmetteric dimethyl arginine, serum lipid profiles, Serum vaspin |
Genetic associations (0)
None linked.